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the major direct regulators of Rac-GEF activity. For ex-
ample, Vav1 can be phosphorylated on tyrosine 174 and
activated by Lck (Crespo et al., 1997; Han et al., 1997).
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gets of PtdIns(3,4,5)P3 typically possess a PH domain
that can bind the lipid and drive translocation of the
host protein to the site of PtdIns(3,4,5)P3 accumulationSummary
in the plasma membrane (not all PH domains bind
PtdIns(3,4,5)P3; Lemmon and Ferguson, 2000). In manyRac, a member of the Rho family of monomeric
cells, type 1 PI3Ks have been shown to be necessaryGTPases, is an integrator of intracellular signaling in
for receptor-driven stimulation of Rac, and activateda wide range of cellular processes. We have purified
type 1 PI3Ks are sufficient to activate Rac (Hawkins eta PtdIns(3,4,5)P3-sensitive activator of Rac from neu-
al., 1995; Reif et al., 1996). These pathways are widelytrophil cytosol. It is an abundant, 185 kDa guanine-
important and underpin responses such as lamellipodianucleotide exchange factor (GEF), which we cloned
formation and associated membrane ruffling and possi-and named P-Rex1. The recombinant enzyme has Rac-
bly ROS formation. Despite this, the mechanisms byGEF activity that is directly, substantially, and syner-
which type 1 PI3Ks and/or PtdIns(3,4,5)P3 can activategistically activated by PtdIns(3,4,5)P3 and Gs both
Rac are unclear in many cellular contexts. This is partlyin vitro and in vivo. P-Rex1 antisense oligonucleotides
a consequence of the fact that no Rac-GEFs have beenreduced endogenous P-Rex1 expression and C5a-
purified and identified on the basis of their activity and,stimulated reactive oxygen species formation in a neu-
relevantly here, from a cellular context that displaystrophil-like cell line. P-Rex1 appears to be a coinci-
PI3K-dependent activation of Rac. On the basis of stud-dence detector in PtdIns(3,4,5)P3 and G signaling
ies subsequent to their original discovery and character-pathways that is particularly adapted to function
ization, four subgroups of the currently known Rac-GEFsdownstream of heterotrimeric G proteins in neutro-
have been claimed to be regulated in a PI3K-dependentphils.
fashion, namely Tiam, Vav, Sos, and PIX. However, these
effects of PI3K and/or PtdIns(3,4,5)P3 are, where direct,Introduction
small or, where indirect, via modulation of unknown or
phosphorylation-based mechanisms (Han et al., 1998;Monomeric GTPases are key regulators of intracellular
Rameh et al., 1997; Fleming et al., 2000; Buchanan et
signaling (Bourne et al., 1990). Rac proteins (Rac1, 2,
al., 2000; Yoshii et al., 1999; Scita et al., 1999; Das et
and 3) are a subfamily of the Rho family of monomeric
al., 2000; Nimnual et al., 1998).
GTPases involved in receptor-regulated responses such In neutrophil-like cells, Rac plays important roles in a
as transcriptional activation, lamellipodia formation, and variety of signaling pathways, particularly activation of
stimulation of reactive oxygen species (ROS) production PAK kinases and phospholipase D and, further down-
(Tapon and Hall, 1997). Rho family monomeric GTPases stream, responses such as chemotaxis, phagocytosis,
are molecular switches that are either “on” and can and ROS formation (Roberts et al., 1999; Dorseuil et al.,
activate effector proteins when GTP bound or “off” when 1992). Its roles in coordinating receptor-stimulated ROS
they are GDP bound. The GTPases can be activated by formation are probably best understood. Rac (Rac2 in
guanine-nucleotide exchange factors (GEFs) that act most species) is, along with p47phox, p67phox, gp91phox, and
to accelerate nucleotide exchange by prising open the gp22phox, a component of the catalytically active NADPH
binding site of specifically the GDP bound form of the oxidase complex that is assembled on the phagosomal/
GTPases (Worthylake et al., 2000). endosomal or plasma membrane of appropriately stimu-
There is a large family of Rac-GEFs (though some can lated cells (Babior, 1999). This process has been corre-
also act as GEFs for other monomeric GTPases). These lated with activation of Rac (Akasaki et al., 1999; Benard
include Vav (1, 2, 3), Tiam (1, 2), PIX (, ), Ras-GRF et al., 1999). It has been demonstrated to be inhibited by
(1, 2), and Sos (Manser et al., 1998; Scita et al., 1999; Rac-GTPase activating proteins (GAPs) in vitro (Geiszt
Stam and Collard, 1999). Protein kinases currently seem et al., 2001), augmented in Rac-GAP knockouts (Bcr)
(Roberts et al., 1999), and inhibited in some immunodefi-
cient patients that carry key mutations in Rac2 (Ambruso4 Correspondence: len.stephens@bbsrc.ac.uk
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et al., 2000), and GTP bound but not GDP bound Rac mation but acted synergistically when added together
(Figure 1A). These effects were all inhibited by the potentcan both bind p67phox and p91phox and activate PAK ki-
nases that are claimed to phosphorylate p47 and p67phox PI3K inhibitor wortmannin, suggesting they were the
result of PI3K activity, although we noted that the effects(Babior, 1999). However, some work suggests that re-
ceptor-stimulated ROS formation can occur without ac- of Gs alone were surprisingly less wortmannin sen-
sitive. Addition of chemically synthesized phospho-tivation of Rac (Geijsen et al., 1999), implying basal levels
of GTP-Rac are sufficient, or simply not necessary, for inositides in the form of liposomes showed that the
biological diastereoisomer of PtdIns(3,4,5)P3 could po-some regulatory mechanisms.
There is evidence that PI3Ks play a key role in neutro- tently activate ROS formation (Figure 1B). The stereo-
selectivity of these results suggests these effects arephils in mediating signaling between activation of G pro-
tein-linked receptors and stimulation of ROS formation. not the result of a physico-chemical property of the
added PtdIns(3,4,5)P3 and support the results obtainedType 1B PI3K nullizygotes fail to produce, and PI3K
inhibitors block, ROS formation in response to inflamma- above where the PI3K phosphorylates membrane lipids
and hence creates membrane-localized lipid products.tory mediators (Condliffe and Hawkins, 2000). The mech-
anism, however, by which PI3Ks contribute to driving In context of the literature defining an important role
for PI3Ks in activation of Rac and the important partROS formation is unclear. We have shown that PtdIns3P
(a potential breakdown product of PtdIns(3,4,5)P3) regu- Rac plays in the assembly of the NADPH oxidase com-
plex, we asked the question, do these effects dependlates ROS formation via binding to the PX domain of
p40phox, an effect that can be detected in the presence on activation of Rac? By adding small amounts of pure,
recombinant, posttranslationally lipid-modified EE-of GTPS-Rac and hence cannot involve Rac activation
(Ellson et al., 2001). Some data supports the idea that Rac1 and [-32P]GTP into these assays, we could show
p101/p110-PI3K and G can independently and, inin neutrophils, type 1 PI3Ks may be upstream of activa-
tion of Rac. The PI3K inhibitors LY294002 and wortman- combination, synergistically activate Rac (Figure 1C).
p101/p110-PI3K, both alone and when in synergisticnin have been shown to significantly reduce activation
of Rac in response to inflammatory mediators (Akasaki combination with very low concentrations of Gs, stim-
ulated activation of Rac1 in a significantly wortmannin-et al., 1999; Benard et al., 1999). However, one paper
has presented convincing data showing that fMLP-stim- sensitive fashion. In contrast, higher concentrations of
Gs stimulated Rac1 activation in a wortmannin-resis-ulated activation of Rac is resistant to PI3K inhibitors,
apparently contradicting the work described above (but tant fashion. PtdIns(3,4,5)P3 alone also stimulated acti-
vation of Rac1. These results suggested Rac could besee Discussion) (Geijsen et al., 1999), and has instead,
along with the precedent set by p115Rho-GEF that is acting downstream of p101/p110-PI3K in this system.
We sought to test this by attempting to inhibit activationactivated by G13 (Hart et al., 1998), lead to the sugges-
tion that a G subunit may activate one or more neutro- of Rac by preincubating our cytosolic and membrane
fractions with pure, lipid-modified dominant-negativephil Rac-GEF activities (Geijsen et al., 1999).
The identity of the Rac-GEF(s) that is (are) involved in N17-Rac1. This treatment significantly inhibited p101/
p110-PI3K- and G-mediated activation of ROS for-receptor-stimulated activation of Rac and/or ROS for-
mation in neutrophils remain unknown. In the context mation (Figure 1A). Further increases in N17-Rac1 con-
centration did not result in any greater inhibition (notof the distributions and properties of the known Rac-
GEFs and the types of receptors that can drive ROS shown). PtdIns(3,4,5)P3-stimulated ROS formation was
also inhibited by N17-Rac1, although less efficiently thanformation, it seems plausible that Vav and/or Sos pro-
teins could be downstream of the protein-tyrosine- for PI3K-stimulated ROS formation (mean of 35%, data
not shown).linked receptors while there are no clear candidates
for a similar role downstream of the G protein-linked The above data suggest that Rac can act downstream
of p101/p110-PI3K, G, and PtdIns(3,4,5)P3 in stimula-receptors.
tion of ROS formation in these assays. We tested
whether purified, recombinant, lipid-modified Rac couldResults
stimulate ROS formation. GTPS-Rac1 stimulated ROS
formation substantially more effectively than GDP-Rac1PI3K-, G-, and PtdIns(3,4,5)P3-Regulation
or GTPS-treated N17-Rac1 (Figure 1D). The implicationof Rac Activation and ROS Formation
of this result is that activation of Rac can be sufficientMixtures of cytosol and low-density membranes from
to stimulate ROS formation. However, this is in the con-neutrophils can be stimulated to produce ROS by the
text of complex mixtures of neutrophil cytosol and mem-addition of amphiphiles such as SDS and arachidonic
brane fractions and hence, these effects may in factacid. We tested the idea that type 1 PI3Ks could operate
depend on other signals. The PtdIns(3,4,5)P3-dependentupstream of ROS formation by adding combinations
Rac1 activation we observed in this system suggestedof purified, recombinant p101/p110-PI3K and purified
to us that this effect is mediated by PtdIns(3,4,5)P3-Gs (either recombinant SF9-derived G12 or bovine
sensitive Rac-GEF(s) present in either the neutrophil cy-brain Gs, both of which can substantially activate
tosol or membrane fractions.p101/p110-PI3K) in the presence of MgATP and GTP.
We have shown previously that under similar conditions
PtdIns(3,4,5)P3, PtdIns(3,4)P2, and PtdIns3P are synthe- Purification of a PtdIns(3,4,5)P3-Sensitive Rac-GEF
from Neutrophil Cytosol Fractionssized in these assays (Pacold et al., 2000). Although the
assays contain endogenous PI3Ks and Gs, the added We found the PtdIns(3,4,5)P3-stimulated Rac-GEF activ-
ity was recovered in cytosol fractions and attempted torecombinant proteins independently activated ROS for-
P-Rex1, a PI3K- and G-Regulated Rac-GEF
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Figure 1. PI3K and G Regulate Rac Activation and ROS Formation
(A) PI3K and G synergistically stimulate ROS formation. Neutrophil cytosol and low-density membranes were incubated with 45 nM
recombinant p101/p110 PI3K and/or 54 nM bovine brain G, either with wortmannin (200 nM, gray bars) or without (black bars) or with
dominant-negative N17-Rac (200 nM, white bars), and ROS formation (SPC, single photon counts in 0.1 min) was measured. Data are means
(n  4)  SD from two experiments.
(B) PtdIns(3,4,5)P3 stimulates ROS formation. Neutrophil cytosol and low-density membranes were incubated with isomers of PtdIns(3,4,5)P3,
PtdIns(3,4)P2, or PtdIns(4,5)P2 (S/A, stearoyl-arachidonyl; P/P, dipalmitoyl), and ROS formation was measured. Data are means (n  2–6) 
range.
(C) PI3K and G synergistically stimulate Rac. Neutrophil cytosol and low-density membranes were incubated with PI3K (50 nM), PtdIns(3,4,5)P3
(30 M), and/or G (40 nM at left, 200 nM at right) either with (gray bars) or without (black bars) wortmannin (200 nM), and incorporation of
[-32P]GTP into EE-Rac1 (30 nM) was quantified (means [n  4–8]  SD from four experiments).
(D) Active Rac induces ROS formation. Neutrophil cytosol and low-density membranes were incubated either with wt-Rac (black bars) or
dominant-negative N17-Rac (200 nM, white bars), preloaded and incubated with the indicated guanine nucleotides and, for wt-Rac, with
wortmannin (200 nM, gray bar), and ROS formation was measured. Data are means (n  2–6)  range from three experiments.
purify the enzyme(s) responsible from this source (Figure by MALDI-TOF and N-terminal sequencing. This estab-
lished that the 142 kDa minor band was almost certainly2). The assay used during the purification was a modifi-
cation of the assay used above and quantitated Rac- a proteolytic fragment of the major band. We named
the protein P-Rex1, for PtdIns(3,4,5)P3-dependent RacGEF activity in terms of enhanced [35S]GTPS binding
to pure, recombinant, lipid-modified EE-Rac1 in the exchanger.
presence of mixed phospholipid liposomes (PtdCho,
PtdS, PtdIns) either with or without PtdIns(3,4,5)P3 (10 Cloning and Expression of Human P-Rex1
We cloned the relevant human gene using a combinationM final). Fractionation of cytosol on fast-flow Q-sepha-
rose resolved a major peak of PtdIns(3,4,5)P3-sensitive of library screening from random-primed human U937
cell and spleen cDNA libraries and PCR from a humanRac-GEF activity. This peak of activity was further puri-
fied via SP-sepharose, heparin sepharose, gel-filtration, leukocyte marathon-ready cDNA library. Together these
approaches yielded a full-length ORF of 4980 bp (EMBLand Mono S (Figure 2A) to yield a preparation that con-
tained only two detectable proteins, a major band of and GenBank accession number AJ320261), with the
start ATG being preceded by a passable Kozak se-196 kDa and a minor band of 142 kDa, both of which
perfectly correlated with the elution profiles of Rac-GEF quence and a CG-rich region at the N terminus but no
upstream stop codon, leaving a small possibility thatactivity during the last two columns (Figure 2B). Both
proteins were transferred to nitrocellulose and digested we have not identified the true start ATG. Underlying
genomic sequence showed that the coding sequencewith trypsin, and the resulting peptides were analyzed
Cell
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Figure 2. Purification of a PtdIns(3,4,5)P3-Dependent Rac-GEF Activity from Pig Leukocyte Cytosol
(A) Chromatography profiles. The PtdIns(3,4,5)P3-dependent Rac-GEF activity was purified from 90 l pigs’ blood using this column sequence.
The dotted line represents absorbtion at 280 nm; the dashed line shows salt concentration. Column fractions were assayed for Rac-GEF
activity using liposomes either with (thick black line) or without (thick gray line) PtdIns(3,4,5)P3. Gray bars represent the fractions selected for
the following purification step.
(B) Silver-stained SDS-PAGE of fractions, including the peak of PtdIns(3,4,5)P3-dependent Rac-GEF activity recovered from columns at the
gel filtration (1% fraction vol.) and Mono S (1.67% fraction vol.) purification steps.
(C) Purification summary. The absolute activity of the starting material (100%) was calculated to be stimulating the loading of 1.4 pmol of
GTPS onto Rac (above Rac alone) min1 mg1 protein, in the presence of PtdIns(3,4,5)P3, under the conditions described in Experimental
Procedures.
of P-Rex1 is arranged into 41 exons, stretched over more EE-epitope tag in Cos-7 cells, and anti-EE Western blots
revealed a protein with an apparent MW of 197 kDa inthan 300 kb of chromosome 20 at q13.13 (AL131078,
AL049541, AL445192, AL035106, AL133342). It also re- the cell lysates (Figure 4B).
vealed the potential existence of a splice variant and a
potential homolog on chromosome 8 (see database en- PtdIns(3,4,5)P3- and G-Dependent Activation
of Rac by P-Rex1 In Vitrotry EST BAB14375).
The P-Rex1 protein sequence is 1659 amino acids We expressed P-Rex1 with an N-terminal EE-tag in SF9
cells. The protein expressed well and could be purifiedlong, predicting a protein of 185 kDa, and harbors all five
tryptic peptides obtained from the purified pig enzyme to greater than 95% purity in one step using a mono-
clonal anti-EE antibody crosslinked to protein G seph-(Figure 3A). The protein contains a tandem DH/PH do-
main typical of Rho family GEFs, two DEP and two PDZ arose.
Recombinant P-Rex1 displayed PtdIns(3,4,5)P3-sen-domains, and significant similarity over its C-terminal
half to Inositol Polyphosphate 4-Phosphatase (Fig- sitive Rac-GEF activity very similar to that of the purified
protein. We tested the specificity of P-Rex1 for variousure 3B).
We have studied P-Rex1 mRNA expression by prob- Rho family GTPases and Rac proteins that were with or
without posttranslational lipid modifications or carrieding human multiple-tissue Northern blots from Clontech
with a probe made from 673 bp of the P-Rex1 coding different epitope tags. P-Rex1 displayed similar
PtdIns(3,4,5)P3-sensitive activity against Rac1, Rac2,sequence. The Northern blots revealed a major band of
approximately 6 kb, which is consistent with the ex- and CDC42 and low activity against RhoA (Figure 4C).
Interestingly, the Rac1 protein did not need to be lipidpected size of full-length P-Rex1 mRNA, and a minor
band just below. They show that P-Rex1 is expressed modified to serve as a substrate in the context of these
assays (Figure 4C).mainly in peripheral blood leukocytes and brain, less in
spleen and lymph nodes, and much weaker in most Further analysis of the Rac-GEF activity of P-Rex1
showed that PtdIns(3,4,5)P3 had a 50% maximal effectother tissues (Figure 4A).
We transiently expressed P-Rex1 with an N-terminal at 0.3 M (Figure 5A), at which concentration P-Rex1
P-Rex1, a PI3K- and G-Regulated Rac-GEF
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Figure 3. Structure of Human P-Rex1
(A) Amino acid sequence of human P-Rex1. Tryptic peptides obtained from purified P-Rex1 are underlined in black. Protein homology domains
are highlighted.
(B) Schematic representation of the domain structure of P-Rex1.
was significantly selective for the biological D-diaste- these lipid preparations activate PKB completely stereo-
specifically and PDK-1 with equivalent partial selectivityreoisomer of PtdIns(3,4,5)P3 compared to its other
diastereoisomers (Figure 5B). When different phospho- (Stephens et al., 1998). We assume this reflects a fatty
acid-sensitive interaction between the phosphoinosi-inositides were compared at 10 M, P-Rex1 was still
selective for PtdIns(3,4,5)P3, with a weak activation by tides and the proteins that bind them.
We have analyzed the interaction between solublethe biological diastereoisomer of PtdIns(3,4)P2, but not
by other phosphoinositides (Figure 5B). We observed P-Rex1 and PtdIns(3,4,5)P3- or PtdIns(3,4)P2-containing
phospholipid vesicles, immobilized on a dextran-coatedthat P-Rex1 was activated by dipalmitoyl PtdIns(3,4,5)P3
in an apparently more stereo-selective fashion than by L1 gold chip, utilizing surface plasmon energy transfer
technology (Biacore). P-Rex1 binding to phospholipidstearoyl-arachidonyl lipids. We have observed a similar
effect with ARAP3 (Krugmann et al., 2002); however, vesicles was substantially augmented by the inclusion
Cell
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Figure 4. Expression and Substrate Specificity of Human P-Rex1
(A) Northern blots. Multiple-tissue Northern blots from Clontech were probed for P-Rex1 mRNA expression.
(B) Western blot. EE-epitope-tagged P-Rex1 was transiently expressed in Cos-7 cells, then extracted with 1% Triton-X100, containing buffer,
and aliquots of a 10,000 g supernatant (equivalent to 5 	 103, 5 	 104, 5 	 105 cells/lane) were immunoblotted with anti-EE antibody.
(C) Recombinant human P-Rex1 GEF activity was assayed using liposomes (PtdCho, PtdS, PtdIns, 200 M each) with (dark bars) or without
(light bars) PtdIns(3,4,5)P3 (10 M) and the indicated purified GTPases (100 nM). Data are duplicate means  range from one of three
experiments.
of PtdIns(3,4,5)P3 and to a lesser extent by PtdIns(3,4)P2 inhibited by prebinding with purified GDP bound G
and, in the case of the recombinant Gs, dependent(Figure 5C). The presence of PtdIns(3,5)P2, PtdIns(4,5)P2,
PtdIns3P, PtdIns4P, or PtdIns5P in the phospholipid on their posttranslational lipid modifications (Figure 5E).
G alone or in the presence of AlF did not activatevesicles increased P-Rex1 binding only weakly. These
results are consistent with the idea that PtdIns(3,4,5)P3 P-Rex1 Rac-GEF activity. It should be noted that cholate
(the detergent we use in the storage buffer for our prepa-has a direct effect on P-Rex1 in our assay rather than
indirect effect by, for example, influencing the distribu- rations of Gs and G proteins) strongly inhibits
P-Rex1 Rac-GEF activity; consequently, the scale oftion of Rac or the ability of Rac to interact with P-Rex1.
Although we had no direct assay data to support the the effects of Gs in an experiment are a combined
function of the G and the total cholate concentrations.possibility that Gs could activate P-Rex1 directly, the
presence of the DEP domains, which commonly occur We tested the effects of combinations of Gs and
PtdIns(3,4,5)P3 (Figure 5F). P-Rex1 was activated syner-in proteins that interact with heterotrimeric G-proteins,
and our earlier results with neutrophil cytosol/membrane gistically by Gs and PtdIns(3,4,5)P3, suggesting that
their effects are mediated via distinct mechanisms.mixtures encouraged us to test the effects of Gs on
P-Rex1 Rac-GEF activity. Pure Gs from bovine brain
and prepared as recombinant EE-G12 from coinfected PtdIns(3,4,5)P3- and G-Dependent Activation
of Rac by P-Rex1 In VivoSF9 cells both activated P-Rex1 Rac-GEF activity in
vitro (Figures 5D and 5E). The effects of Gs were To address questions about the selectivity of P-Rex1
for Rac versus CDC42 in cells and the physiologicalabolished by preheating (95
C for 30 min), substantially
P-Rex1, a PI3K- and G-Regulated Rac-GEF
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Figure 5. Regulation of Recombinant Human P-Rex1 Rac-GEF Activity by PtdIns(3,4,5)P3 and G In Vitro
(A) PtdIns(3,4,5)P3 dose response. P-Rex1-dependent activation of EE-Rac1 was assayed in the presence of liposomes containing 200 M
each of PtdCho, PtdS, PtdIns, and the indicated concentrations of PtdIns(3,4,5)P3 (final P-Rex1 concentration was 100 nM). Data are means
(n  2–4)  range from two pooled experiments.
(B) Lipid specificity of P-Rex1-dependent activation of Rac was measured in the presence of liposomes (as in [A]) with either 10 M (dark
bars) or 0.3 M (white inset bars) of the indicated phosphoinositides (S/A, stearoyl-arachidonyl; P/P, dipalmitoyl). Data are duplicate means 
range obtained from one of two separate experiments.
(C) Phosphoinositide-dependent binding of P-Rex1 (100 nM) to liposomes containing PtdCho, PtdS, PtdE (330 M each), and the indicated
phosphoinositides (6 mol-%) was measuresd by Biacore. Data are means  SD from four pooled experiments.
(D) G dose response. P-Rex1-dependent activation of Rac was assayed using the indicated concentrations of purified bovine brain G.
Final cholate concentration was 0.0072% except for 1 M G samples (0.0104%). Data are duplicate means  range from one of three
experiments.
(E) Controls for G effects. P-Rex1-dependent activation of Rac was assayed using, where indicated, G (0.3 M, bovine brain-derived
except where indicated to be prenylated or nonprenylated, which were derived from Sf9 cells), mixed G subunits (0.23 M), AlF (10 M),
boiled bovine brain G (0.5 M), recombinant prenylated G (0.5 M), or recombinant nonprenylated G (0.5 M). For combinations of
G and G, these (or control buffers) were preincubated for 30 min on ice. Final cholate concentration was 0.012%. Data are duplicate
means  range from one experiment.
(F) Synergy between PtdIns(3,4,5)P3 (0.2 M) and bovine brain G (0.3 M) in the regulation of P-Rex1 Rac-GEF activity. Final cholate
concentration was 0.0048%. Data are duplicate means  range from one of three experiments.
significance of the effects of Gs and PtdIns(3,4,5)P3 PtdIns(3,4,5)P3 and GTP-Rac clearly showed that Rac
activation in the presence of Gs and PI3K was sub-we have observed in the test tube, we prepared the
relevant baculoviruses to allow us to study the act- stantially bigger than could be accounted for by the
increase in PtdIns(3,4,5)P3 alone (Figure 6C).ivation of endogenous Rac and CDC42 in SF9 cells. We
found that SF9 cells infected with baculoviruses driv-
ing P-Rex1, p101/p110-PI3K, and G12 production P-Rex1 Induces a Phenotype Like Constitutively
Active Rac in PDGF-Stimulated PAE Cellsshowed substantial increases in the levels of endoge-
nous GTP-Rac but no change in the levels of endoge- We sought evidence that P-Rex1 can be regulated by
signaling pathways downstream of cell-surface recep-nous GTP-CDC42, suggesting that in vivo P-Rex1 acts
as a Rac-GEF (Figure 6A). Furthermore, the pattern of tors and act as a Rac-GEF in mammalian cells. We used
a porcine aortic endothelial (PAE) cell line that stablyactivation of Rac by p101/p110-PI3K and G12 was
consistent with our in vitro results, showing synergistic overexpresses the PDGF receptor. In these cells,
PDGF stimulates PtdIns(3,4,5)P3 accumulation, wort-activation of P-Rex1 Rac-GEF activity (Figures 6A and
6B). Although coexpression of PI3K and G led to sig- mannin-sensitive activation of Rac, and Rac-dependent
membrane ruffling and lamellipodia formation, and sta-nificantly higher PtdIns(3,4,5)P3 production than PI3K
expression alone, direct comparison of the increases in ble overexpression of constitutively active V12-Rac
Cell
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Figure 6. Rac-GEF Activity of Human Recombinant P-Rex1 In Vivo
(A) Western blots of Rac activation by P-Rex1 in vivo. Aliquots of 5 	 106 Sf9 cells in 6 cm dishes were infected with combinations of viruses
encoding P-Rex1, G1, G2, p101, p110, or control viruses where indicated. After 42.5 hr in growth medium, then 4 hr serum-free, the cells
were subjected to a PAK-Crib pull-down assay. Immunoblots were probed with anti-Rac (top and second gels) or anti-CDC42 (third gel)
antibodies. The equivalent of 0.18 dishes of cells was loaded from PAK-Crib pulldowns and 0.05 dishes for total lysates. The bottom gel
shows the second panel filter after staining with Coomassie.
(B) Synergistic PI3K and G-dependent activation of Rac by P-Rex1 in vivo. Sf9 cells were infected with the above viruses as indicated,
then treated as in (A). ECL-exposed films were digitized, and the data shown are means  range (n  4) from two pooled experiments.
(C) G and/or PI3K-induced formation of PtdIns(3,4,5)P3 in Sf9 cells was measured (data are means [n  5]  range) and plotted against
P-Rex1-dependent G and/or PI3K-induced activation of Rac (data from [B]).
causes the formation of strongly exaggerated lamelli- pathways downstream of cell surface receptors in mam-
malian cells.podia (“fried eggs”; Figure 7A; Hawkins et al., 1995;
Welch et al., 1998).
PAE cells were transiently transfected with N-ter- Agonist-Stimulated ROS Formation
in a Neutrophil-like Cell Lineminally myc-tagged P-Rex1 and serum starved, and the
effects of PDGF stimulation on cell shape and the distri- Is Dependent on P-Rex1
We treated a promyelocytic cell line (NB4) with retinoicbution of myc-P-Rex1 were analyzed by indirect immu-
nofluorescence microscopy (Figure 7B). In unstimulated acid and either phosphorothioate antisense oligonucle-
otide targeted against P-Rex1 or a randomized controlcells, P-Rex1 localization was mainly cytosolic, although
some seemed plasma membrane bound, and the cells oligonucleotide. After 2 days, both populations of cells
had differentiated normally and displayed indistinguish-had the typical basal shape. However, in about 30% of
unstimulated cells, P-Rex1 expression resulted in the able MapK activation in response to C5a (Figure 8C)
and expression of -COP (not shown). In contrast, information of strongly exaggerated lamellipodia (fried
eggs) that appeared identical to those induced by con- the antisense-treated cultures specifically, the levels of
P-Rex1 fell by 80%–85% (Figure 8B), and C5a-stimu-stitutively active V12-Rac. The proportion of cells show-
ing the V12-Rac-like phenotype was reduced in cells lated ROS formation fell by about 40%–45% (Figure 8A).
treated with wortmannin (Figures 7B and 7C), sug-
gesting that it was induced by basal PI3K activity. PDGF P-Rex1 Has No Obvious Inositol Polyphosphate
4-Phosphatase Activitystimulation resulted in a wortmannin-sensitive increase
of V12-Rac-like phenotype to 80% of P-Rex1-expressing Finally, as the C-terminal half of P-Rex1 has substantial
homology with Inositol Polyphosphate 4-Phosphatase,cells. This phenotype was specific to P-Rex1-positive cells
and not induced by DAPP1 in parallel experiments. In we attempted to determine whether the protein pos-
sessed Inositol Polyphosphate 4-Phosphatase activitycells showing the V12-Rac-like phenotype, P-Rex1 lo-
calization was still mainly cytosolic, but there was signifi- using 32P-PtdIns(3,4,5)P3 and 32P-PtdIns(3,4)P2 as sub-
strates and Inositol Polyphosphate 4-Phosphatase andcant costaining with the subcortical actin ring at the
edge of the lamellipodia and a small variable accumula- SHIP-1 as controls. We also used paranitrophenolphos-
phate as a broad spectrum substrate in a protein phos-tion of P-Rex1 in the plasma membrane. However, the
plasma membrane translocation was weaker and less phatase assay, using calf intestinal alkaline phospha-
tase and MEG-2 tyrosine phosphatase as controls. Atclear than for DAPP1 in parallel experiments. Similar
experiments, in which we examined the distribution of P-Rex1 concentrations of up to 1.45 M and 192 nM,
respectively, in these assays, the enzyme exhibited noGFP-tagged P-Rex1 in control and PDGF-stimulated
PAE cells by live imaging with a scanning confocal mi- lipid or protein phosphatase activity.
croscope, gave the same results (not shown). Therefore,
although PI3K activation does not cause a large-scale Discussion
translocation of P-Rex1 to the plasma membrane, it is
sufficient to induce strong P-Rex1-mediated lamelli- To our knowledge, no Rho family or Ras family GEFs
have been successfully purified and identified on thepodia formation. These results suggest that P-Rex1 can
act as a Rac-GEF and can be regulated by signaling basis of their GEF activity. In the case of the Rac-GEFs,
P-Rex1, a PI3K- and G-Regulated Rac-GEF
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Figure 7. P-Rex1 Induces a Phenotype Like Activated Rac in PAE Cells
(A) Immunofluorescence micrographs of serum-starved normal (first and second images) or stably V12-Rac transfected (third image) PAE
cells after stimulation with 10 ng/ml PDGF for 5 min (second image) or without (first and third images). Fixed cells were labeled with FITC-
phalloidin to stain filamentous actin.
(B and C) Expression of P-Rex1 in PAE cells. Myc-tagged P-Rex1 or DAPP1 were transiently expressed in PAE cells. These were grown (10
hr), serum starved (8 hr), treated with wortmannin (100 nM, 10 min) or not, and then stimulated with a range of PDGF concentrations for 5
min, as indicated. Cells were fixed and stained with anti-myc antibody followed by FITC secondary antibody to label P-Rex1 or DAPP1 and
with TRITC-phalloidin to label filamentous actin.
(B) Immunofluorescence micrographs.
(C) Quantification of immunofluorescence microscopy data. Results were obtained by counting 100 P-Rex1-positive cells (dark bars) or DAPP1-
positive cells (light bars) per coverslip. P-Rex1 data are from duplicate coverslips (means  range) from one of two independent experiments.
DAPP1 data are from one coverslip per condition from one experiment.
this means that activities in lysates or those involved in vesicles. However, P-Rex1 does not substantially translo-
cate from the cytosol to the sites of PtdIns(3,4,5)P3 accu-specific signaling events have only rarely been attrib-
uted to a specific GEF and further, that the contributions mulation in vivo; rather, the enzyme is partially localized
to the membrane in serum-starved cells. The implicationany GEF makes toward total cellular GEF activities are
unclear. We have resolved neutrophil cytosol by chro- of these results is that PtdIns(3,4,5)P3 is able to activate
the enzyme by inducing a catalytically significant con-matography on Q-Sepharose and found a major peak
of PtdIns(3,4,5)P3-sensitive Rac-GEF activity (in the formational shift or by reorientating P-Rex1 at the mem-
brane surface rather than by targeting it to the mem-presence of PtdIns(3,4,5)P3, it represented about 65%
of total Rac-GEF activity), which we have purified, brane. This is totally compatible with the emerging view
of the role of the PH domain in the tandem DH/PH do-cloned, and named P-Rex1. P-Rex1 is a surprisingly
abundant protein, about 0.1% of cytosolic protein (cf. mains of Rho family GEFs as a phosphoinositide-inhib-
ited repressor of DH domain GEF activity (Worthylake0.001% for the type 1B PI3K purified from similar frac-
tions). et al., 2000; see Introduction). This is quite distinct to
the generally accepted view of the role of the PH domainOur results show that PtdIns(3,4,5)P3 can substantially
activate P-Rex1 Rac-GEF activity in vitro and that cell in proteins such as PLCwhere lipid binding acts purely
as a membrane-targeting device.surface receptors can activate P-Rex1 in a PI3K-depen-
dent fashion in vivo. Further, we demonstrate P-Rex1 can Some data has suggested that activation of hetero-
trimeric G proteins in neutrophil-like cells can stimulateselectively bind PtdIns(3,4,5)P3-containing phospholipid
Cell
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to independent sites, although we have not identified
these sites. P-Rex1, hence, becomes one of a growing
list of effector proteins that are regulated by G sub-
units in neutrophils, including p101/110-PI3K and
PLCs (Sternweis and Smrcka, 1992; see Introduction).
G protein-mediated signaling pathways in neutrophils
respond rapidly, e.g., maximal activation of Rac can
occur within 10 s. The fact that both p101/p110-PI3K
and P-Rex1 appear to be partially membrane localized
in serum-starved cells and are activated at the level of
the membrane without any requirement for translocation
from the cytosol (Krugmann et al., 2002) probably con-
tributes to this rapidity.
Our data are consistent with the existence of a signal-
ing pathway in neutrophils from G protein-linked recep-
tors and via Gs, type 1B PI3K, PtdIns(3,4,5)P3, and
activation of Rac to enhanced ROS formation. There is
significant work that has also suggested these links;
however, this appeared weak in the absence of an ap-
propriate Rac-GEF. The literature also contains high-
quality work that is apparently inconsistent with this
model: activation of Rac by ligands such as fMLP has
been shown to be resistant to PI3K inhibitors (Geijsen
et al., 1999; see Introduction). Our results offer a possible
explanation; they suggest that at the earliest times of
stimulation with ligands like fMLP, G activation of
P-Rex1 may be more important than activation via
PtdIns(3,4,5)P3, as the levels of PtdIns(3,4,5)P3 rise due
to G stimulation of p101/p110-PI3K. Moreover, this
phenomenon would be exaggerated in unprimed neutro-
phils, which produce up to 20 times less PtdIns(3,4,5)P3
in response to fMLP (Condliffe and Hawkins, 2000). This
is exactly what is observed in the literature: workers
with demonstratedly unprimed neutrophils who also
stimulate for the shortest times (10 s) found Rac activa-
tion by fMLP to be largely resistant to PI3K inhibitors
(Geijsen et al., 1999). Those workers who tested PI3K
inhibitors at later times of stimulation (1 min) find that
PI3K inhibitors substantially, but not completely, inhibit
activation of Rac (Akasaki et al., 1999; Benard et al.,
Figure 8. P-Rex1 Is Necessary for ROS Formation
1999).
Human promyelocytic NB4 cells were differentiated for 2 days with
P-Rex1 is a coincidence detector apparently designed1 M all-trans retinoic acid and treated with 10 M of either P-Rex1
to respond to the combined versus isolated appearanceantisense oligonucleotide or randomized control oligonucleotide
of PtdIns(3,4,5)P3 and G, probably in the same mem-and then subjected to the experiments below.
(A) Oligonucleotide-treated NB4 cells were stimulated with 0.15 nM brane. In neutrophils, this set of signals is naturally deliv-
C5a, and ROS formation (SPC, single photon counts) was measured. ered by activation of G protein-linked receptors in the
Data are mean  SD (n  4) from one of three experiments. context of a large population of Gi proteins in the plasma(B) Total lysates of P-Rex1-transfected or control Cos7 cells, human
membrane and G-sensitive p101/110-PI3K (that isneutrophils, or oligonucleotide-treated NB4 cells were analyzed for
particularly enriched in hematopoietically-derived cells),P-Rex1 expression level by Western blot using a polyclonal anti-
P-Rex1 antibody. which drives accumulation of PtdIns(3,4,5)P3 in the
(C) Oligonucleotide-treated NB4 cells were serum-starved and then membranes actually harboring Gs (Stephens et al.,
stimulated with C5a as indicated for 3 min at RT. MapK activation 1997). The importance of this synergy is possibly re-
was measured by Western blot using a phospho-MapK antibody flected in the fact that ligands like GM-CSF that activate
and densitometric scanning of the blots. Data are mean  range
type 1A PI3Ks primarily via protein-tyrosine kinase-(n  2) from two experiments.
based mechanisms do not cause detectable activation
of Rac (Geijsen et al., 1999), despite the fact that they
cause significant accumulation of PtdIns(3,4,5)P3 (CoreyRac-GEF activities (Geijsen et al., 1999), and further-
et al., 1993). In other cellular contexts, perhaps in themore, a small (about 40% above control) effect of Gon
brain, it is easy to imagine that P-Rex1 could be relevantRac-GEF activity in neutrophil lysates has been reported
in the detection of specific patterns of signaling that(Arcaro, 1998). P-Rex1 is an example of a Rac-GEF that
deliver coincident activation of type 1A PI3Ks and acti-can be activated directly by G. The ability of Gs
vation of Gi/Go proteins. This type of regulation couldand PtdIns(3,4,5)P3 to synergistically activate P-Rex1
suggests that these regulators can bind simultaneously be particularly significant in forming or strengthening
P-Rex1, a PI3K- and G-Regulated Rac-GEF
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Rac1 were quantified by scintillation counting (blanks without EE-particular cell contacts in view of the key role Rac plays
Rac1 were subtracted).in, for example, neurite outgrowth (Luo et al., 1997).
Rac-GEF Assay for P-Rex1 PurificationExperimental Procedures
and Recombinant P-Rex1
Liposomes (phosphatidylcholine [PtdCho], phosphatidylserineMaterials
[PtdS], phosphatidylinositol [PtdIns]; final assay concentration 200Monomeric GTPases (EE-Rac1, GST-Rac1, EE-N17 Rac1, EE-Rac2,
M each) were sonicated in lipid buffer (20 mM HEPES/NaOH [pHGST-CDC42, and GST-RhoA) were purified from Sf9 cells in the
7.5; 4
C], 100 mM NaCl, 1 mM EGTA) with or without PtdIns(3,4,5)P3GDP bound state to 95% purity and were stored in 1% (w/v)
(final assay concentration 10 M) and were incubated for 10 mincholate, 5 M GDP, 5 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.15 M
on ice with 2l of purified, GDP-loaded, recombinant, lipid-modifiedNaCl, 40 mM HEPES/NaOH (pH 7.4; 4
C). Non-lipid-modified GST-
EE-Rac1 in 5 mM MgCl2, 50 mg/ml BSA, 5 mM DTT, 20 mM HEPES/Rac was derived from bacteria.
NaOH (pH 7.5; 4
C), 100 mM NaCl, 1 mM EGTA (final assay concen-G were purified from bovine brain (Sternweis and Robishaw,
tration 100 nM EE-Rac1, 0.0024% cholate). Then, 4 l of Rac-GEF1984) or from Sf9 cells (both wild-type EE-1,2 and nonprenylated
activity (cytosol, column fractions, or recombinant P-Rex1) wasmutants EE-1,C186S-2) and stored in 1% cholate, 1 mM DTT, 20
added, followed by 2l GTPS (in lipid buffer, final assay concentra-mM HEPES/NaOH (pH 8.0; 4
C), 5 M GDP (for bovine brain Gs),
tion 5 M, including 1 Ci [35S]GTPS). After 10 min at 30
C, theand 1 mM EDTA. G subunits (a mixture of i1, i2, and o) were
reaction was stopped and EE-Rac1 was pulled down using anti-EEpurified from bovine brain (Sternweis and Pang, 1990) and stored
antibodies coupled to protein G sepharose, and [35S]GTPS-loadingin 50 mM HEPES/NaOH (pH 8.0; 4
C), 1 mM EDTA, 1 mM DTT, 100
of Rac was detected by scintillation  counting. RecombinantmM NaCl, 1% cholate, and 10M GDP. Phosphorothioate antisense
P-Rex1 was diluted in “buffer A” (20 mM HEPES/NaOH [pH 7.5;oligonucleotides and controls directed to P-Rex1 have been de-
4
C], 1% betaine, 0.01% Na azide, 0.5 mM EGTA, 200 mM KCl, 10%signed and manufactured by BIOGNOSTIK, Go¨ttingen, Germany
ethylene glycol) to a final assay concentration of 50 nM. In assays(antisense, TCA TTG ATG GAG TAG ATC; randomized control, ACT
with G, 2 l of G in buffer A were added to the liposome/RacACT ACA CTA GAC TAC).
mix before the 10 min on ice, and P-Rex1 was added as 5X.Recombinant EE-p101/hexa-His-p110 PI3K was produced from
Sf9 cells (Stephens et al., 1997). Recombinant NH2-terminally EE-
tagged P-Rex1 was purified from Sf9 cells utilizing the EE-tag and Purification of PtdIns(3,4,5)P3-Dependent Rac-GEF
Neutrophil-enriched leukocytes prepared from 90 l pigs’ blood werestored in PBS, 1 mM EGTA, 1 mM DTT, 0.01% Na azide.
Stearyl-arachidonyl (S/A)-PtdIns(3,4,5)P3 stereoisomers were syn- sonicated in 30 mM Tris/HCl (pH 7.8; 4
C), 0.1 M NaCl, 4 mM EGTA,
1 mM DTT, 0.1 mM PMSF, and 0.5X antiproteases. The cytosolthesized by P. Gaffney (Gaffney and Reese, 1997). All dipalmitoyl
(P/P)-phosphoinositides were made by G. Painter (Painter et al., (100,000 	 g supernatant) was diluted to 16.7 mM NaCl in “buffer
B” (0.5 mM EGTA, 10% ethylene glycol, 1% betaine, 0.01% Na azide,1999). In this manuscript, the term PtdIns(3,4,5)P3 refers to D/D-(S/
A)-PtdIns(3,4,5)P3 unless otherwise stated. 1 mM DTT, 50 M PMSF, and 0.1X antiproteases) containing 10
mM Tris/HCl (pH 7.8; 4
C) applied to a 400 ml Q-sepharose fast-Two independent affinity-purified sheep polyclonal anti-P-Rex1
antibodies (raised against conjugated peptides based on P-Rex1 flow column equilibrated in buffer B containing 30 mM Tris/HCl (pH
7.8; 4
C) and 0.1 mM EDTA, and was eluted with a 0.1–0.6 M NaClsequence, CLHPEPQSQHE and CAAARESERQLRLR) were pooled
and used to detect endogenous and heterologous P-Rex1 by immu- gradient over 3 l. The peak of PtdIns(3,4,5)P3-dependent Rac-GEF
activity eluted between 0.43 and 0.52 M NaCl, was desalted on anoblotting.
1.4 l G25-fine column equilibrated in buffer B containing 20 mM
HEPES/NaOH (pH 6.8; 4
C), and then was applied to a 50 ml SP-ROS Formation Assay with Neutrophil Cytosol
sepharose-HP column equilibrated in the same buffer and elutedand Membrane Fractions
with a 0.25–0.75 M KCl gradient over 500 ml. The activity was recov-Neutrophil-enriched leukocytes were isolated from pigs’ blood, son-
ered between 0.31 and 0.375 M KCl, desalted on a 300 ml G25-fineicated in 0.25 M sucrose, 0.1 M KCl, 50 mM HEPES/NaOH (pH 7.2;
column equilibrated in buffer B containing 20 mM HEPES/NaOH (pH4
C), 1 mM DTT, 2 mM EGTA, 0.1 mM PMSF, and 1X antiproteases
7.2; 4
C), applied onto a 12 ml Heparin sepharose column equili-(20 g/ml each of antipain, aprotinin, pepstatin, and leupetin), and
brated the same buffer, and eluted with a 0.1–0.7 M KCl gradientcentrifuged (100,000 	 g, 1 h, 4
C) to yield cytosol and light mem-
over 150 ml. The activity was recovered between 0.55 and 0.69 Mbrane fractions (4.5 mg/ml protein, collected between 0.60 and 1.35
KCl. A fraction corresponding to 0.60–0.65 M salt, selected for goodM sucrose and washed in sonication buffer). Light membranes (3 l)
fold purification, was concentrated, pH adjusted, and applied to awere premixed with G subunits, p101/p110-PI3K, and/or N17-
200 ml HPLC size exclusion column equilibrated in buffer B con-Rac (or boiled controls) in 6 l containing 5 mM ATP, 8 mM MgCl2,
taining 20 mM HEPES/NaOH (pH 6.9; 4
C) and 120 mM NaCl. The20 mM HEPES/NaOH (pH 7.5; 4
C), 2 mM EGTA, 10 mM
activity was recovered after 104 ml, corresponding to an apparent-glycerophosphate, 0.1 mM ortho-vanadate, 0.1 M KCl, 1 mM DTT,
size of 203 kDa, loaded onto a 1 ml Mono S FPLC column equili-0.01% (w/v) Na azide. After 25 min on ice, 20 l was added con-
brated in buffer B containing 20 mM HEPES/NaOH (pH 7.0; 4
C),taining 15l cytosol and 1 mM MgGTP, 20M FAD, 400M NADPH,
and eluted with a 0.1–0.7 M KCl gradient over 54 ml. The pure,and 200 M luminol. After 8 min at RT, single photon counts (SPC)
PtdIns(3,4,5)P3-dependent Rac-GEF activity eluted between 0.375per 0.1 min were quantitated in a scintillation counter at intervals
and 0.425 M KCl.of 3–5 min for up to 20 min (blanks without cytosol were subtracted).
When lipids were added, they were preincubated with the mem-
branes, and 10 M GTPS replaced MgGTP. Where wortmannin Cloning of Human P-Rex1
was added, it was preincubated with both cytosol and membrane A tryptic digest of purified pig PtdIns(3,4,5)P3-dependent Rac-GEF
fractions for 15 min on ice. Where EE-Rac1 was added, it was yielded five peptides (T14, T30, T44, T69, and T72) that were ana-
preloaded with different guanine nucleotides at a 5-fold excess over lyzed by MALDI-TOF and N-terminal sequencing. T72 was identical
bound GDP. to mouse Est AA796530 (homologous to Tiam). T14 and T69 were
near identical to mouse Est A1466041 (homolgous to Inositol Poly-
phosphate 4-Phosphatase). T30 and T44 were uncharacterized. Un-Rac-GEF Assay with Neutrophil Cytosol
and Membrane Fractions derlying human genomic sequence placed T44 into the Inositol
Polyphosphate 4-Phosphatase homology region and T72 near theThis assay was essentially as for ROS production, except pure,
lipid-modified EE-Rac1 (30–50 nM final concentration) was added N terminus of a predicted protein. A predicted partial sequence
encompassing these regions has been published (Nagase et al.,to the cytosol, and GTP, GTPS, NADPH, FAD, and luminol were
omitted. Three minutes after mixing membrane and cytosol frac- 2000). Est AA796530 was cut with Bgl2 and labeled with [-32P]dCTP
using the prime-a-gene system (Promega) to make a 673 bp probetions, [-32P]GTP (20 Ci per sample) was added. Four minutes later,
the reaction was stopped and EE-Rac1 was pulled down using anti- for screening a human U937 cell random prime -Zap2 cDNA library
and a human spleen random prime GT11 cDNA library, yielding 24EE antibody coupled to protein G sepharose. The total dpm on EE-
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